Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 40.16
(0.27%)
CNY 40.16
(0.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.8 Billion CNY | 7.23% |
| 2022 | 1.68 Billion CNY | 2.77% |
| 2021 | 1.63 Billion CNY | 6.38% |
| 2020 | 1.54 Billion CNY | 281.09% |
| 2019 | 404.21 Million CNY | 31.09% |
| 2018 | 308.36 Million CNY | 25.06% |
| 2017 | 246.57 Million CNY | 45.29% |
| 2016 | 169.7 Million CNY | 33.9% |
| 2015 | 126.74 Million CNY | 55.82% |
| 2014 | 81.34 Million CNY | 13.77% |
| 2013 | 71.49 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.74 Billion CNY | -2.92% |
| 2024 Q1 | 1.79 Billion CNY | -0.53% |
| 2024 Q3 | 1.77 Billion CNY | 1.79% |
| 2023 Q2 | 1.71 Billion CNY | -0.45% |
| 2023 Q3 | 1.74 Billion CNY | 1.61% |
| 2023 FY | 1.8 Billion CNY | 7.23% |
| 2023 Q4 | 1.8 Billion CNY | 3.74% |
| 2023 Q1 | 1.72 Billion CNY | 2.19% |
| 2022 Q2 | 1.55 Billion CNY | -4.59% |
| 2022 Q1 | 1.63 Billion CNY | -0.34% |
| 2022 FY | 1.68 Billion CNY | 2.77% |
| 2022 Q4 | 1.68 Billion CNY | 6.59% |
| 2022 Q3 | 1.58 Billion CNY | 1.4% |
| 2021 Q2 | 1.52 Billion CNY | -1.51% |
| 2021 Q4 | 1.63 Billion CNY | 4.6% |
| 2021 FY | 1.63 Billion CNY | 6.38% |
| 2021 Q1 | 1.54 Billion CNY | 0.51% |
| 2021 Q3 | 1.56 Billion CNY | 2.73% |
| 2020 Q3 | 1.47 Billion CNY | 295.67% |
| 2020 FY | 1.54 Billion CNY | 281.09% |
| 2020 Q1 | 370.91 Million CNY | -8.24% |
| 2020 Q4 | 1.54 Billion CNY | 4.71% |
| 2020 Q2 | 371.8 Million CNY | 0.24% |
| 2019 Q2 | 304.19 Million CNY | 0.0% |
| 2019 Q4 | 404.21 Million CNY | 0.0% |
| 2019 FY | 404.21 Million CNY | 31.09% |
| 2018 FY | 308.36 Million CNY | 25.06% |
| 2017 FY | 246.57 Million CNY | 45.29% |
| 2016 FY | 169.7 Million CNY | 33.9% |
| 2016 Q1 | 126.05 Million CNY | 0.0% |
| 2016 Q2 | 126.05 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 126.74 Million CNY | 55.82% |
| 2014 FY | 81.34 Million CNY | 13.77% |
| 2013 FY | 71.49 Million CNY | 0.0% |